These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 21696604)

  • 1. Decision curve analysis revisited: overall net benefit, relationships to ROC curve analysis, and application to case-control studies.
    Rousson V; Zumbrunn T
    BMC Med Inform Decis Mak; 2011 Jun; 11():45. PubMed ID: 21696604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding decision curve analysis in clinical prediction model research.
    Zhao L; Leng Y; Hu Y; Xiao J; Li Q; Liu C; Mao Y
    Postgrad Med J; 2024 Jun; 100(1185):512-515. PubMed ID: 38453146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decision curve analysis: confidence intervals and hypothesis testing for net benefit.
    Vickers AJ; Van Claster B; Wynants L; Steyerberg EW
    Diagn Progn Res; 2023 Jun; 7(1):11. PubMed ID: 37277840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statistical inference for net benefit measures in biomarker validation studies.
    Marsh TL; Janes H; Pepe MS
    Biometrics; 2020 Sep; 76(3):843-852. PubMed ID: 31732971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calibration of risk prediction models: impact on decision-analytic performance.
    Van Calster B; Vickers AJ
    Med Decis Making; 2015 Feb; 35(2):162-9. PubMed ID: 25155798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the Clinical Impact of Risk Prediction Models With Decision Curves: Guidance for Correct Interpretation and Appropriate Use.
    Kerr KF; Brown MD; Zhu K; Janes H
    J Clin Oncol; 2016 Jul; 34(21):2534-40. PubMed ID: 27247223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reporting and Interpreting Decision Curve Analysis: A Guide for Investigators.
    Van Calster B; Wynants L; Verbeek JFM; Verbakel JY; Christodoulou E; Vickers AJ; Roobol MJ; Steyerberg EW
    Eur Urol; 2018 Dec; 74(6):796-804. PubMed ID: 30241973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A simple, step-by-step guide to interpreting decision curve analysis.
    Vickers AJ; van Calster B; Steyerberg EW
    Diagn Progn Res; 2019; 3():18. PubMed ID: 31592444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement.
    Collins GS; Reitsma JB; Altman DG; Moons KG
    BMJ; 2015 Jan; 350():g7594. PubMed ID: 25569120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nomograms in oncology: more than meets the eye.
    Balachandran VP; Gonen M; Smith JJ; DeMatteo RP
    Lancet Oncol; 2015 Apr; 16(4):e173-80. PubMed ID: 25846097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time-dependent ROC curve analysis in medical research: current methods and applications.
    Kamarudin AN; Cox T; Kolamunnage-Dona R
    BMC Med Res Methodol; 2017 Apr; 17(1):53. PubMed ID: 28388943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and Validation of a Radiomics Nomogram for Preoperative Prediction of Lymph Node Metastasis in Colorectal Cancer.
    Huang YQ; Liang CH; He L; Tian J; Liang CS; Chen X; Ma ZL; Liu ZY
    J Clin Oncol; 2016 Jun; 34(18):2157-64. PubMed ID: 27138577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration.
    Moons KG; Altman DG; Reitsma JB; Ioannidis JP; Macaskill P; Steyerberg EW; Vickers AJ; Ransohoff DF; Collins GS
    Ann Intern Med; 2015 Jan; 162(1):W1-73. PubMed ID: 25560730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy.
    Wang Y; Li J; Xia Y; Gong R; Wang K; Yan Z; Wan X; Liu G; Wu D; Shi L; Lau W; Wu M; Shen F
    J Clin Oncol; 2013 Mar; 31(9):1188-95. PubMed ID: 23358969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reclassification calibration test for censored survival data: performance and comparison to goodness-of-fit criteria.
    Demler OV; Paynter NP; Cook NR
    Diagn Progn Res; 2018; 2():. PubMed ID: 30984876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discrimination and Calibration of Clinical Prediction Models: Users' Guides to the Medical Literature.
    Alba AC; Agoritsas T; Walsh M; Hanna S; Iorio A; Devereaux PJ; McGinn T; Guyatt G
    JAMA; 2017 Oct; 318(14):1377-1384. PubMed ID: 29049590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using the weighted area under the net benefit curve for decision curve analysis.
    Talluri R; Shete S
    BMC Med Inform Decis Mak; 2016 Jul; 16():94. PubMed ID: 27431531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Net benefit approaches to the evaluation of prediction models, molecular markers, and diagnostic tests.
    Vickers AJ; Van Calster B; Steyerberg EW
    BMJ; 2016 Jan; 352():i6. PubMed ID: 26810254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decision curve analysis.
    Fitzgerald M; Saville BR; Lewis RJ
    JAMA; 2015 Jan; 313(4):409-10. PubMed ID: 25626037
    [No Abstract]   [Full Text] [Related]  

  • 20. Prognosis Research Strategy (PROGRESS) 3: prognostic model research.
    Steyerberg EW; Moons KG; van der Windt DA; Hayden JA; Perel P; Schroter S; Riley RD; Hemingway H; Altman DG;
    PLoS Med; 2013; 10(2):e1001381. PubMed ID: 23393430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.